The Dividend Yield as of September 2024 (TTM) for Kronos Bio, Inc. (KRON) is 0%

According to Kronos Bio, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 0%. This represents a change of 0% compared to the average of 0% of the last 4 quarters.

Kronos Bio, Inc. (KRON) Historical Dividend Yield (quarterly & annually)

How has KRON Dividend Yield performed in the past?

The mean historical Dividend Yield of Kronos Bio, Inc. over the last ten years is 0%. The current 0% Dividend Yield has changed 0% with respect to the historical average. Over the past ten years (40 quarters), KRON's Dividend Yield was at its highest in in the March 2019 quarter at 0%. The Dividend Yield was at its lowest in in the March 2019 quarter at 0%.

Kronos Bio, Inc. (KRON) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of Kronos Bio, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Kronos Bio, Inc. (KRON) Average Dividend Yield

How has KRON Dividend Yield performed in the past?

The current Dividend Yield of Kronos Bio, Inc. (KRON) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Kronos Bio, Inc. (KRON) Dividend Yield vs. Peers

How is KRON’s Dividend Yield compared to its peers?

Kronos Bio, Inc.’s Dividend Yield is less than Cyclerion Therapeutics, Inc. (0%), less than Larimar Therapeutics, Inc. (0%), less than Addex Therapeutics Ltd (0%), less than Achilles Therapeutics plc (0%), less than NextCure, Inc. (0%), less than CytomX Therapeutics, Inc. (0%), less than Neoleukin Therapeutics, Inc. (0%), less than Spero Therapeutics, Inc. (0%), less than Assembly Biosciences, Inc. (0%), less than Replimune Group, Inc. (0%), less than Nuvectis Pharma, Inc. (0%), less than Lyra Therapeutics, Inc. (0%), less than Gossamer Bio, Inc. (0%), less than Crinetics Pharmaceuticals, Inc. (0%), less than Inhibrx, Inc. (4.81%), less than Merus N.V. (0%), less than Lyell Immunopharma, Inc. (0%), less than Generation Bio Co. (0%), less than Erasca, Inc. (0%), less than C4 Therapeutics, Inc. (0%), less than Edgewise Therapeutics, Inc. (0%),

Build a custom stock screener for Kronos Bio, Inc. (KRON) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Kronos Bio, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Kronos Bio, Inc. (KRON) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Kronos Bio, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.